Background/Aims: Nattokinase is a serine protease produced by Bacillus subtilis during the fermentation of the soybean product natto. The fibrinolytic activity and thrombolytic effects of nattokinase have been observed in vitro, but the effect in vivo has still to be researched. The objective of this study was to demonstrate the activity of nattokinase in vivo. Methods: To establish a rat model of thrombosis, κ-carrageenan was injected subcutaneously into the toes of Sprague-Dawley (SD) rats. Histological examination confirmed thrombosis. The rats were then treated with varying doses of nattokinase and the resulting thrombolysis was histologically assessed. ELISA was used to determine the levels of the fibrin/fibrinogen degradation products (FDPs) and D-dimer, which are sensitive indices of fibrinolytic activity. Vermis kinase, a known thrombolytic agent, was used as a positive control. Results: Biopsy results revealed partial thrombolysis in the tail vessels of the rats treated with nattokinase or vermis kinase. FDP and D-dimer levels were higher in rats treated with high-dose nattokinase than in those treated with saline. No difference in FDP or D-dimer levels was observed between rats treated with high-dose nattokinase and those treated with vermis kinase. Conclusions: Both the histological and physiological evidence from this study indicate that nattokinase exerts thrombolytic effects in vivo.

Keywords:
Nattokinase, Thrombolytic effect, κ-Carrageenan, Sprague-Dawley rats, Thrombosis model
1.
White GC: Current status of thrombolytics - the need for better, especially safer, agents. Thromb Res 2008;122:S1-S2.
2.
Nakajima N, Taya N, Sumi H: Potent fibrinolytic enzyme from the lysate of Katsuwonus pelamis digestive tract (Shiokara): purification and characterization. Biosci Biotechnol Biochem 1993;57:1604-1605.
3.
Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H: A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto; a typical and popular soybean food in the Japanese diet. Experientia 1987;43:1110-1111.
4.
Thomas JP, Geiger PG, Girotti AM: Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide-and iron-mediated reactions. J Lipid Res 1993;34:479-490.
5.
Kim JY, Gum SN, Paik JK, Lim HH, Kim KC, Ogasawara K, Inoue K, Park S, Jang Y, Lee JH: Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertens Res 2008;31:1583-1588.
6.
Kaida T, Matsuno H, Niwa M, Kozawa O, Miyata H, Uematsu T: Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Thromb Haemost 1997;77:562-567.
7.
Hsia CH, Shen MC, Lin JS, Wen YK, Hwang KL, Cham TM, Yang NC: Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res 2009;29:190-196.
8.
Astrup T, Mullertz, S: The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952;40:346-351.
9.
Sumi, H: The method of determination of the thrombolytic enzyme nattokinase. J Brew Soc Japan 1993;88:4822-4831.
10.
Kamiya S, Hagimori M, Ogasawara M, Arakawa M: In vivo evaluation method of the effect of nattokinase on carrageenan-induced tail thrombosis in a rat model. Acta Haematol 2010;124:218-224.
11.
Bekemeier H, Giessler AJ: Thrombosis induction by different carrageenans in rats and mice. Naturwissenschaften 1987;74:345-346.
12.
Wang GQ, Xu T, Bu XM, Liu BY: Anti-inflammation effects of corn silk in a rat model of carrageenin-induced pleurisy. Inflammation 2010;34:639-644.
13.
Hagimori M, Kamiya S, Yamaguchi Y, Arakawa M: Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model. Pharmacol Res 2009;60:320-323.
14.
Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S: Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol Pharm Bull 1995;18:1387-1391.
15.
Suzuki Y, Kondo K, Ichise H, Tsukamoto Y, Urano T, Umemura K: Dietary supplementation with fermented soybeans suppresses intimal thickening. Nutrition 2003;19:261-264.
16.
Ero MP, Ng CM, Mihailovski T, Harvey NR, Lewis BH: A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose. Altern Ther Health Med 2013;3:16-19.
17.
Hwang CM, Kim DI, Huh SH, Min BG, Park JH, Han JS, Lee BB, Kim YI, Ryu ES, Kim JW: In vivo evaluation of lum-brokinase, a fibrinolytic enzyme extracted from Lumbricus rubellus, in a prosthetic vascular graft. Cardiovasc Surg (Torino) 2002;43:891-894.
18.
Hsia CH, Shen MC, Lin JS, Wen YK, Hwang KL, Cham TM, Yang NC: Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res 2009;29:190-196.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.